Anti-LNX1 Antibody

Targets the LNX1 protein, a PDZ domain-containing RING-type E3 ubiquitin ligase best known for binding and ubiquitinating Numb during cell fate decisions and neuronal development. Raised in rabbit as a polyclonal reagent and supplied by Antibodies.com at 1 mg/ml in PBS with 0.1% sodium azide and 50% glycerol, this unconjugated primary antibody is validated for Western blot, immunohistochemistry, and immunofluorescence on human samples. Each vial contains 100 µl of antibody, sufficient for dozens of blot or staining experiments depending on dilution. Researchers studying Notch signalling, neural progenitor differentiation, tight junction biology, or the ubiquitin–proteasome system frequently use LNX1 antibodies to probe expression patterns and interaction partners. Store the glycerol stock at -20 °C in working aliquots to limit freeze-thaw cycles and protect reagent activity. For research use only.